Lyophilisation for Pharmaceuticals 2008

Lyophilisation for Pharmaceuticals 2008
3RD – 5TH SEPTEMBER 2008, BSG CONFERENCE CENTRE, LONDON, UK

Harnessing the freeze-drying process for product delivery to reduce overheads and increase profits "The market for lyophilised biologicals is expected to reach 150 million units by 2010”

Genetic Engineering & Biotechnology News

Dear Colleague,

Over the last few years, lyophilisation has become a crucial enabling process technology for many important drugs. It has meant that material can be easily stored, shipped and later reconstituted to its original form for injection, and this has brought many new applications and the possibility for reducing costs. If you have not yet taken steps in this direction, or you’d like to know how to improve your portfolio, our lineup of expert speakers at the 2008 Lyophilisation conference will be on hand to share their knowledge and experience. This one-off event promises to bring together leaders in the field, so why not take the time to reserve your place? However, freeze-drying is also a complex, costly, and facility-intensive process that many companies do, but only a few do well. By attending this conference, you will fi nd out what steps need to be taken in order to stay competitive, and also to keep on the right side of the regulators. And with the fi eld of drug discovery now experiencing impressive advancements through maturing technologies, those at the forefront will lead the way in this profi table sector. Reserving a place at this conference will provide a practical approach to help you develop strategies for successful formulation, lyo cycle development and optimisation, validation, and scale-up.Visiongain’s hotly-anticipated event will enable you to examine the latest technological breakthroughs, discuss and debate scientifi c processes, share the expert’s opinions on all aspects of lyophilisation, and forge the right partnerships for the coming years. Places are limited, so I invite you to book now to avoid missing out on what promises to be a unique exchange of knowledge and ideas.

I hope to see you there.

Best regards,

Dr Richard Walledge

Senior Conference Producer

Who should attend?

• Head of Drug Development Strategy
• Director of Drug Safety/Risk Management
• Head of Project Packaging
• VP/Head of Research & Development and Product Safety/Stability Assessment
• VP/Head of Patient Safety and Outcomes Research and Data Analysis
• VP/Head of Regulatory Affairs and Compliance
• VP of Sales & Marketing

Sponsorship and exhibition opportunities:

This event offers a unique opportunity to meet and do business with some of the key players in the pharmaceutical and biotech industries. If you have a service or product to promote, you can do so at this event by:

• Hosting a networking drinks reception
• Taking an exhibition space at the conference
• Advertising in the delegate documentation pack
• Providing branded bags, pens, gifts, etc.

If you would like more information on the range of sponsorship or exhibition possibilities for Lyophilisation for Pharmaceuticals 2008 Conference, please contact:

S. Raju
Tel: (00 91 22) 27578668 / 27579438
Email: raju@bharatbook.com

Troubleshooting the freeze-drying process

• Identifying defects in products
• How to improve reliability and reproducibility

Critical Assessment of Freeze Dried Materials

• Visually assess a series of lyophilised products whose different freeze-drying characteristics mean that they have dried to exhibit a range of structural patterns
• Evaluating the critical temperature
• Analysing the propensity of a formulation to form a surface skin on Scale-up of the freeze-drying process
• From small to large
• Pre-empting problems encountered

Multi-disciplinary Problem Solving Exercise

• Identifing the issues that are likely to contribute to product defects
• What steps might be taken to resolve the problem?
• How to produce a URS document

For more information kindly visit: http://www.bharatbook.com/seminars/Lyophilisation_for_Pharmaceuticals_2008.asp